HANNA KACKIELO

Allopathic & Osteopathic Physicians|Internal Medicine NORWICH, CT NPI 1598714701

General Payments — all program years on this page

$1,623.41

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 101
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $238.73 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $238.7310

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $69.043
Acerta Pharma LLC $58.332
GlaxoSmithKline, LLC. $41.692
Boehringer Ingelheim Pharmaceuticals, Inc. $29.221
ABBVIE INC. $20.641
Lilly USA, LLC $19.811

By program year

Program yearAmountRecords
2018 $394.4024
2019 $574.6448
2020 $80.034
2021 $20.021
2022 $133.966
2023 $181.638
2024 $238.7310

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096897354 Novo Nordisk Inc $19.80 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096934095 Novo Nordisk Inc $26.09 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097479755 Novo Nordisk Inc $23.15 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104017384 ABBVIE INC. $20.64 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104501618 AstraZeneca Pharmaceuticals LP $28.40 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104698948 AstraZeneca Pharmaceuticals LP $29.93 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115834406 GlaxoSmithKline, LLC. $20.19 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116676413 GlaxoSmithKline, LLC. $21.50 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118074346 Boehringer Ingelheim Pharmaceuticals, Inc. $29.22 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135019890 Lilly USA, LLC $19.81 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.